Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-0.10
%1.83
Latest5.55
High5.75
Low5.20
Volume588,740
Turnover (SEK)3,251,930
Market Cap (MSEK)297

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
12:54 PMAVANON5.5520
12:50 PMAVANON5.50580
12:50 PMAVANON5.501,420
12:49 PMENSNON5.503,580
12:46 PMENSSWB5.505,393
12:45 PMAVANON5.552,988
12:45 PMAVANRD5.55562
12:42 PMAVANRD5.551,050
12:42 PMAVANRD5.55388
12:37 PMAVAAVA5.55112

Scheduled Reports

DateReport
2017-08-23Bokslutskommuniké för 2016/2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se